Discover Mental Health
November 27, 2025
Sean M. Viña
The renewed interest in psychedelics for mental health treatment presents both promise and complexity. Substances like psilocybin and MDMA have shown potential in addressing conditions such as PTSD and depression, particularly when administered in supportive contexts. Yet as these therapies move toward mainstream adoption, concerns arise about rapid medicalization, corporate monopolization, and...
Medicine India
November 25, 2025
Shilpa Bharat Mendon
Professional associations in cardiovascular medicine do not view psychosocial distress as a risk factor for cardiovascular disease (CVD) on its own. Nonetheless, a number of experts think that assessing for psychological distress can improve the prediction of CVD risk. Persistence and commitment to complex lifestyle modifications aimed at lowering the risk of CVD are significantly influenced by...
Research Square
November 25, 2025
Nai‐kong V. Cheung
1 citation
preprint
Abstract Traditional monoaminergic medications often offer limited relief for the physical and cognitive symptoms of post-traumatic stress disorder (PTSD) and complex PTSD. Growing data now point to fast-acting, glutamate-based treatments that boost synaptic plasticity and interrupt fear-conditioned neural circuits. We report four sequential cases of hard-to-treat trauma-spectrum...
Psychedelics
November 15, 2025
Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta et al.
Serotonergic psychedelics like psilocybin and LSD have shown potential therapeutic benefits for mental health conditions, including depression, PTSD, and addiction. However, research remains limited due to regulatory barriers and a lack of diversity in study populations. Spanish-speaking individuals, despite their significant global and U.S. presence, are underrepresented in psychedelic...
Molecular Psychiatry
November 14, 2025
Núria Nadal‐gratacós, Pol Puigseslloses, Laura Hernández‐guzmán et al.
Psychedelics have garnered significant interest for their therapeutic potential in mental health conditions such as depression, anxiety, and post-traumatic stress disorder. While research has primarily focused on well-studied psychedelics, phenethylamine derivatives have also gathered interest for their potential therapeutic applications. Thus, this study aims to investigate the pharmacological...
Berkeley Scientific Journal
November 13, 2025
Ana Sofia Brito
Interview with Dr. Andrea Gomez
DELOS Desarrollo Local Sostenible
November 12, 2025
Maria Eduarda Mesquita Gonsalves, Beatriz Moreira Brazil, Maurício Cupello Peixoto
O Transtorno de Estresse Pós-Traumático (TEPT) é uma condição mental que pode surgir após experiências traumáticas, afetando a qualidade de vida dos indivíduos. O tratamento convencional envolve psicoterapia e farmacoterapia, contudo, nem sempre apresenta resultados satisfatórios. Nesse cenário, a psicoterapia assistida por 3,4-metilenodioximetanfetamina (MDMA) tem emergido como alternativa...
Healthcare
November 7, 2025
Francesca Scafuto, Rossella Mattea Quinto, Graziella Orrù et al.
Background: Contemplative practices encompass a variety of static and dynamic practices. These practices, by fostering insights, heightened awareness, and a deeper connection to a broader framework of meaning, may play a crucial role in significantly reducing trauma-related symptoms in both young and adult populations. Methods: The current narrative literature review used Scopus and PubMed to...
European Neuropsychopharmacology
November 7, 2025
Mikkel Højlund, Helin Y. Kafali, Begüm Kırmızı et al.
12 citations
Serotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a continuously evolving evidence base. We searched Pubmed/Scopus/clinical trial registries up to 08july2025 for double-blind randomized controlled trials (RCTs) testing MDMA or serotonergic psychedelics in patients with mental disorders. Primary outcomes were change in...
Frontiers in Psychology
November 6, 2025
In recognition of the increasing scholarly and clinical attention to this concept, Frontiers in Psychology established a Mindfulness section in 2022. In this article, we briefly review the conceptualization of mindfulness and its , discuss its different facets, done in the context of the section's third anniversary. Furthermore, we , and discuss how mindfulness, both as a disposition and the...